Advertisement GE Healthcare introduces new modular biopharmaceutical factory - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

GE Healthcare introduces new modular biopharmaceutical factory

GE Healthcare, a healthcare business of GE, has unveiled KUBio, a new off-the-shelf, modular factory that saves biopharmaceuticals producers time and money.

KUBio’s pre-made modules can be assembled at a customer’s chosen site to make a fully functional ready-to-run bioprocessing facility.

KUBio is pre-fabricated and delivered with ready-to-use production line to meet cGMP requirements.

The 1200m² facility uses Ready-to-Process single-use technologies of GE Healthcare, according to the company.

The total planning, delivery and construction time for KUBio is 14-18 months, while the traditional facilities consume nearly 24 -36 months.

The first modular facilities to be introduced will be designed to manufacture monoclonal antibodies.

GE Healthcare is also planning to introduce modules to manufacture other biopharmaceuticals down the line.

GE Healthcare Life Sciences Enterprise Solutions general manager Olivier Loeillot said KUBio is a new approach to the manufacture of biopharmaceuticals.

"With KUBio our customers will be able to cut months off the typical construction time, and greatly streamline the whole construction process,” Loeillot added.

”We’re already seeing interest from a wide range of customers, from governments wanting to develop in-country manufacturing capability right through to pharmaceutical companies wanting to expand production capacity in new locations."